Philadelphia Patient Highlights SMA Type 1 Risks

A three-month-old from Dauphin County is undergoing treatment for the rare genetic disorder in Philadelphia.

Updated on Sept. 27, 2026 in Babies

Bold flat-color editorial illustration depicting vertical structural columns in deep red and cream, evoking the gravity of clinical diagnostic environments.
Three-month-old Harper Cugini is receiving treatment for spinal muscular atrophy Type 1 at the Children's Hospital of Philadelphia. AI Illustration. Upload story photo >

Three-month-old Harper Cugini is currently receiving care at the Children's Hospital of Philadelphia for spinal muscular atrophy (SMA) Type 1. The condition, which impacts muscle and respiratory function, is a rare genetic disorder that can manifest within the first six months of a child's life.

Why it matters

SMA Type 1 is a serious condition that affects approximately one in 10,000 babies nationwide. Early identification is critical, as symptoms can emerge rapidly during early infancy.

Spinal muscular atrophy affects about one in 10,000 babies in the United States. Symptoms frequently appear within the first six months of life, a window during which Harper Cugini has spent her entire life in medical facilities.

The players

Children's Hospital of Philadelphia

A leading pediatric healthcare institution that provides specialized care for children with complex genetic conditions.

Harper Cugini

A three-month-old patient from Dauphin County currently receiving care for spinal muscular atrophy Type 1.

The details

SMA Type 1 is a genetic condition that progressively weakens muscles and bones while impacting the respiratory system. Diagnostic protocols include carrier screening via blood tests for parents, while newborn screening is used to identify the condition in infants before clinical symptoms begin to appear.

Timeline

  1. Symptoms of SMA Type 1 can begin appearing during the first 6 months of life.

The Home Front

This case underscores the role of nationwide newborn screening protocols in identifying rare conditions early. Such diagnostic measures serve as a vital tool for families in managing the complexities of rare genetic health outcomes.

Parents should discuss routine newborn screenings with their pediatrician to understand how genetic conditions are monitored in the first months of life. If you have questions about family health history, consult a genetic counselor to determine if carrier screening is appropriate for your family.

The takeaway

Early awareness of genetic health markers is an essential part of proactive family care. Parents are encouraged to maintain a detailed record of infant health milestones and to discuss any muscle or respiratory concerns with a pediatrician immediately.

Further reading

Learn more about local pediatric resources and health guidance in our Babies section.

Source note: This article includes information reported by WHP.